- Home
- CALC vs PYN Comparison
CALC vs PYN Comparison
Compare CALC & PYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- PYN
- Stock Information
- Founded
- CALC 2011
- PYN 2002
- Country
- CALC United States
- PYN United States
- Employees
- CALC N/A
- PYN N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- PYN Investment Managers
- Sector
- CALC Health Care
- PYN Finance
- Exchange
- CALC Nasdaq
- PYN Nasdaq
- Market Cap
- CALC 22.9M
- PYN 30.1M
- IPO Year
- CALC N/A
- PYN N/A
- Fundamental
- Price
- CALC $2.27
- PYN $5.27
- Analyst Decision
- CALC Strong Buy
- PYN
- Analyst Count
- CALC 2
- PYN 0
- Target Price
- CALC $14.50
- PYN N/A
- AVG Volume (30 Days)
- CALC 47.4K
- PYN 19.9K
- Earning Date
- CALC 08-11-2025
- PYN 01-01-0001
- Dividend Yield
- CALC N/A
- PYN 5.07%
- EPS Growth
- CALC N/A
- PYN N/A
- EPS
- CALC N/A
- PYN N/A
- Revenue
- CALC N/A
- PYN N/A
- Revenue This Year
- CALC N/A
- PYN N/A
- Revenue Next Year
- CALC N/A
- PYN N/A
- P/E Ratio
- CALC N/A
- PYN N/A
- Revenue Growth
- CALC N/A
- PYN N/A
- 52 Week Low
- CALC $1.42
- PYN $4.84
- 52 Week High
- CALC $5.97
- PYN $6.60
- Technical
- Relative Strength Index (RSI)
- CALC 72.98
- PYN 49.80
- Support Level
- CALC $1.59
- PYN $5.25
- Resistance Level
- CALC $2.26
- PYN $5.37
- Average True Range (ATR)
- CALC 0.17
- PYN 0.10
- MACD
- CALC 0.06
- PYN 0.01
- Stochastic Oscillator
- CALC 86.90
- PYN 9.59
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About PYN PIMCO New York Municipal Income Fund III of Beneficial Interest
PIMCO New York Municipal Income Fund III is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State, and New York City income tax. To pursue the objectives, the fund invests a majority of its net assets in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax.